logo

Sierra Oncology, Inc. (DNAI)



Trade DNAI now with
  Date
  Headline
7/7/2021 7:15:51 AM Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
6/23/2021 7:01:17 AM Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
6/21/2021 7:06:26 AM Sierra Oncology Completes Enrollment For MOMENTUM Phase 3 Trial; Topline Data Anticipated In Q1
6/3/2021 7:07:48 AM Sierra Oncology: Georgia Erbez And Christy Oliger Join To Its Board
5/21/2021 7:01:41 AM Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
5/12/2021 10:05:50 AM Sierra Oncology Reports Oral Presentation At European Hematology Association Annual Meeting
5/7/2021 7:15:47 AM Sierra Oncology Q1 Loss Per Share $1.71 Vs Loss Per Share $3.14 Year Ago
3/11/2021 7:14:36 AM Sierra Oncology 2020 Non-GAAP Adjusted Net Loss $53.7 Mln Vs Non-GAAP Adjusted Net Loss $51.2 Mln Last Year
2/12/2021 7:29:43 AM Sierra Oncology Announces Presentation At LifeSci Partners Precision Oncology Day
11/25/2020 7:03:04 AM Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11/5/2020 7:12:52 AM Sierra Oncology Q3 Net Loss $14.5 Mln Vs. Net Loss $12.9 Mln Last Year
10/2/2020 7:01:21 AM Sierra Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8/6/2020 7:27:22 AM Sierra Oncology Q2 Loss/Shr $1.58 Vs Loss $7.97 Last Year
8/6/2020 7:21:35 AM Sierra Oncology Q2 Net Loss $16.5 Mln Vs. Net Loss $14.9 Mln Last Year
6/12/2020 2:33:59 AM Sierra Oncology Presents Long-Term Safety And Dose Intensity Data For Momelotinib
5/26/2020 7:03:42 AM Sierra Oncology Appoints Stephen Dilly As President And CEO
5/7/2020 7:21:01 AM Sierra Oncology Q1 Net Loss $31.9 Mln Vs. Net Loss $13 Mln Last Year
3/3/2020 7:14:55 AM Sierra Oncology Q4 Loss Per Share $7.88 Vs Loss $7.68 Last Year